COVID Pill

• U.S. pharmacists can now prescribe COVID pills. Canada should follow suit, experts say

  The Canadian Pharmacists Association says 'pharmacists in every jurisdiction' should be allowed to prescribe Paxlovid for COVID-19 following U.S. FDA's authorization on Wednesday.

  Health

  Jul 7, 2022
  
• Isolate if you catch COVID again after taking Pfizer’s pill, U.S. CDC says

  Although Pfizer says such incidents are rare, the U.S. CDC advises reinfected COVID patients to isolate for five days even after treatment.

  Health

  May 25, 2022
  
• Advertisement
• Who can get COVID-19 pill Paxlovid in New Brunswick?

  Eligibility for the pill is still narrower in New Brunswick than in some neighbouring provinces. It’s prescribed by primary care providers and available at pharmacies at no cost.

  Health

  Apr 23, 2022
• Advertisement
• Pfizer forecasts higher COVID-19 vaccine, pill sales in 2022, but analysts expected more

  Pfizer raised the guidance on its anticipated vaccine and COVID-19 antiviral pill Paxlovid on Tuesday, but not as high as analysts had been expecting.

  Health

  Feb 8, 2022
• Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized?

  "Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk," said Dr. Gerald Evans of the new COVID-19 treatment.

  Health

  Jan 18, 2022
• Paxlovid pills set to arrive in Saskatchewan this week

  The province stressed the availability of the novel treatments will be limited and that they are not a substitute for getting vaccinated.

  Canada

  Jan 18, 2022
• Canada approved Paxlovid, Pfizer’s new oral COVID pill. What you need to know

  As Canada stares down an expected jump in hospitalizations, Paxlovid could play "an important role" in the fight against COVID-19, according to health officials.

  Canada

  Jan 17, 2022
• Approval of Pfizer COVID-19 pills coming in 7-10 days: Health Canada

  Canadian health leaders have been publicly calling for the medication to be approved. The pills prevent the virus that causes COVID-19 from reproducing within a patient's body.

  Health

  Jan 13, 2022
• Advertisement
• Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home use

  Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce COVID-19 hospitalizations and deaths by around 30 per cent.

  World

  Dec 23, 2021
• Advertisement
• Pfizer to allow other companies to make its COVID-19 pill

  COVID-19 vaccine maker Pfizer has agreed to grant a license for its antiviral pill to the Medicines Patent Pool, which would allow other companies to make the treatment.

  Health

  Nov 16, 2021